Nektar Therapeutics | NKTR - Custo de Mercadoria Vendida

Preço das Ações
73.76
Mudança Diária
1.54 2.13%
Mensal
7.80%
Anual
471.38%
Q1 Previsão
70.05




Custo de Mercadoria Vendida Alterar Data
Agios Pharmaceuticals USD 1.88M 199K 2025-12
ALKERMES USD 46.21M 5.38M 2025-12
Amgen USD 1.79B 128M 2025-12
Baxter International USD 2.4B 512M 2025-12
BioCryst Pharmaceuticals USD 9.52M 7.34M 2025-12
Biogen USD 810.1M 205.1M 2025-09
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Cara Therapeutics USD 0 0 2025-03
Cipla INR 29.1B 1.16B 2025-12
Dr.Reddys Laboratories INR 36.16B 3.75B 2025-12
Eisai JPY 51.08B 5.56B 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Esperion Therapeutics USD 27.85M 13.43M 2025-12
Exelixis USD 26.48M 7.91M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
Grifols EUR 1.51B 184.45M 2025-12
Halozyme Therapeutics USD 102.15M 29.14M 2025-12
Incyte USD 121.18M 22.18M 2025-12
Ionis Pharmaceuticals USD 8M 5.66M 2025-12
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
Karyopharm Therapeutics USD 37.43M 2.41M 2024-09
MacroGenics USD 10.12M 34.18M 2025-12
Merck USD 3.32B 531M 2025-12
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Neurocrine Biosciences USD 17.6M 246.4M 2025-12
Novartis USD 3.54B 3M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sarepta Therapeutics USD 399.38M 247.93M 2025-12
Takeda JPY 401.15B 184.07B 2025-12
Teva Pharmaceutical Industries USD 2.06B 120M 2025-12
Xencor USD 61.66M 50.95M 2025-06